BackgroundCheck.run
Search For

Keith E Friend, 63Moorestown, NJ

Known as:
Keith Eugene Friend Keith G Friend Keith E Freind Kieth Friend Keith Corinne
Related to:
Richard R Friend

Keith Friend Phones & Addresses

Moorestown, NJ   

39 Everitts Hill Rd, Flemington, NJ 08822    908-8064662   

4 Forest View Dr, Gladstone, NJ 07934    908-7190531   

Bellaire, TX   

Houston, TX   

Peapack, NJ   

Bedminster, NJ   

Barnegat, NJ   

Charlottesville, VA   

Education

School / High School: University of Maryland At Baltimore / Professional Schools 1986

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Diabetes, Metabolism & Endocrinology, 1991
Get Report
Control this profile

Mentions for Keith E Friend

Career records & work history

Medicine Doctors

Keith Friend Photo 1

Dr. Keith E Friend, Gladstone NJ - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism
Address:
4 Forest View Dr, Gladstone, NJ 07934
39 Everitts Hill Rd, Flemington, NJ 08822
908-8940192 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1991
Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1986
Medical School
Mercy Medical Center
Graduated: 1986
Medical School
U Va Hlth Scis Ctr
Graduated: 1986
Keith Friend Photo 2

Keith Eugene Friend

Specialties:
Internal Medicine
Endocrinology, Diabetes & Metabolism
Education:
University of Maryland(1986)

Keith Friend resumes & CV records

Resumes

Keith Friend Photo 30

Medical Director

Location:
New York, NY
Industry:
Medical Practice
Work:
Roche Sep 1, 2003 - Nov 1, 2009
Senior Medical Director Baxter International Inc. Sep 1, 2003 - Nov 1, 2009
Medical Director Pfizer 2001 - 2003
Medical Director Endocrinology
Education:
University of Maryland School of Medicine 1982 - 1986
Keith Friend Photo 31

Keith Scott Scottie Melissas Friend

Keith Friend Photo 32

Keith Friend

Keith Friend Photo 33

Keith Friend

Publications & IP owners

Us Patents

Therapeutical Conversion

US Patent:
2005015, Jul 14, 2005
Filed:
May 6, 2004
Appl. No.:
10/840025
Inventors:
Pia Burman - Uppsala, SE
Keith Friend - Flemington NJ, US
International Classification:
A61K038/08
US Classification:
514016000
Abstract:
This invention provides a method of therapeutical conversion from a long-acting release (LAR) formulation of octreotide, e.g. Sandostatin LAR, to pegvisomant (Somavert) for the acromegalic patients through a therapeutically overlapping transition period to a final dose range of pegvisomant established.

Methods And Compositions For Treating, Preventing Or Delaying Onset Of A Neoplasm

US Patent:
2003021, Nov 13, 2003
Filed:
Apr 25, 2003
Appl. No.:
10/423761
Inventors:
Keith Friend - Flemington NJ, US
International Classification:
A61K031/4745
US Classification:
514/283000
Abstract:
Methods of treating, preventing or delaying onset of a neoplasm comprise administering to an individual an anti-neoplastic agent and a growth hormone receptor antagonist. Methods for reducing tumor weight or volume comprise administering to an individual an anti-neoplastic agent and a growth hormone receptor antagonist. Compositions comprise an anti-neoplastic agent and a growth hormone receptor antagonist.

Device-Based Risk Management Of A Therapeutic

US Patent:
2019034, Nov 14, 2019
Filed:
Jul 22, 2019
Appl. No.:
16/518164
Inventors:
- Tokyo, JP
Amy FREEDMAN - Yardley PA, US
Keith FRIEND - Gladstone NJ, US
Elaine A. O'HARA - Malvern PA, US
Craig OSTROFF - East Windsor NJ, US
Marcelo DE FREITAS SANTORO - Chester Springs PA, US
Charles SHINER - Collegeville PA, US
Takeshi WATANABE - Tokyo, JP
Miho YAMAMOTO - Tokyo, JP
Christopher A. ZIMMER - Washington DC, US
Assignee:
Otsuka Pharmaceutical Co., Ltd. - Tokyo
International Classification:
H04L 29/06
G16H 50/20
G16H 50/30
G16H 10/60
G06Q 50/26
G06Q 10/10
Abstract:
A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.

Device-Based Risk Management Of A Therapeutic

US Patent:
2016033, Nov 17, 2016
Filed:
Jul 26, 2016
Appl. No.:
15/219866
Inventors:
- Tokyo, JP
Amy FREEDMAN - Yardley PA, US
Keith FRIEND - Gladstone NJ, US
Elaine A. O'HARA - Malvern PA, US
Craig OSTROFF - East Windsor NJ, US
Marcelo DE FREITAS SANTORO - Chester Springs PA, US
Charles SHINER - Collegeville PA, US
Takeshi WATANABE - Tokyo, JP
Miho YAMAMOTO - Tokyo, JP
Christopher A. ZIMMER - Washington DC, US
Assignee:
Otsuka Pharmaceutical Co., Ltd. - Tokyo
International Classification:
G06F 19/00
H04L 29/06
Abstract:
A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.

Possible Relatives

David R Friend  Debera A Friend  Deborah A Friend  Daniel C Friend  Aaron D Friend  Denise L Friend  Dennis L Friend  Keith A Johnson  Keith J Standish  Keith E Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.